Nature Reviews Drug Discovery



Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomes ()

>> Read More

John Tsai ()

>> Read More

NLRP3 inhibitors stoke anti-inflammatory ambitions ()

>> Read More

FDA approves first-in-class osteoporosis drug ()

>> Read More

Smallest biopharma firms are pushing more of the pipeline ()

>> Read More

Aminoacyl-tRNA synthetases as therapeutic targets ()

>> Read More

Achaogen bankruptcy highlights antibacterial development woes ()

>> Read More

Improving safety and efficacy of immunotherapeutics ()

>> Read More